Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Quadrant Biosciences

Quadrant Biosciences
2012 FOUNDED
PRIVATE STATUS
Later Stage VC LATEST DEAL TYPE
$2.3M LATEST DEAL AMOUNT
2 INVESTORS
Description

Developer of medical screening device designed to provide epigenetic diagnostic solutions. The company's device is involved in exploring and developing novel biomarker technologies with a focus on Autism Spectrum Disorder, concussion and Parkinson's Disease, thereby allowing the healthcare industry to treat patients with autism through early diagnosis.

Formerly Known As
Motion Intelligence
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Diagnostic Equipment
Primary Office
  • 505 Irving Avenue
  • Suite 3100 AB
  • Syracuse, NY 13210
  • United States

+1 (315) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Quadrant Biosciences’s full profile, request a free trial.

Quadrant Biosciences Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Later Stage VC 23-Jan-2020 $2.3M 00.000 Completed Generating Revenue
7. Later Stage VC 27-Jun-2019 00000 00.000 Completed Generating Revenue
6. Grant 19-Jun-2019 000 00.000 Completed Generating Revenue
5. Grant 19-Sep-2018 000 00.000 Completed Generating Revenue
4. Debt - General 01-Mar-2018 00.000 Completed Generating Revenue
3. Early Stage VC (Series A) 13-Dec-2016 00.000 00.000 000.00 Completed Startup
2. Grant 01-Jan-2016 $225K Completed Startup
1. Grant 31-May-2013 $25K Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Quadrant Biosciences Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Series A 0,000,000 00.000000 00 00 00 00 00.000
To view this company’s complete Cap Table, request access »

Quadrant Biosciences Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
National Institutes of Health Government Minority 000 0000 000000 0
CenterState CEO Government 000 0000 000000 0

Quadrant Biosciences Executive Team (12)

Name Title Board
Seat
Contact
Info
Richard Uhlig Founder, Chief Executive Officer and Board Member
Benjamin Perry President
Richard Bongo Chief Financial Officer and Board Member
Bryan Greene Chief Operating Officer
Jeremy Williams Chief Technology Officer

2 Former Executives

You’re viewing 5 of 12 executives. Get the full list »

Quadrant Biosciences Board Members (9)

Name Representing Role Since Contact
Info
Andrew Rock Quadrant Biosciences Board Member 000 0000
Ira Fedder MD Quadrant Biosciences Board Member 000 0000
James Croke JD Quadrant Biosciences General Counsel & Board Member 000 0000
Mary Tyszko Quadrant Biosciences Board Member 000 0000
Peter Cohen Quadrant Biosciences Board Member 000 0000

1 Former Board Member

You’re viewing 5 of 9 board members. Get the full list »